Effect of Piper Betle Nanospray 7% on Inflamation and IL-6 Levels in Postpartum Maternal Wounds : A Study in the Grobogan Regency Area, Central Java in 2025
DOI:
https://doi.org/10.46799/ijssr.v5i6.1271Keywords:
Piper betle nanospray, IL-6, REEDA scale, and postpartum mothersAbstract
Postpartum second-degree perineal lesions are common and trigger an inflammatory response with an increase in IL-6. Suboptimal treatment risks prolonging the inflammatory process and inhibiting wound healing. Piper betle Linn is recognized as an herbal ingredient with anti-inflammatory potential; its nanospray formulation is believed to penetrate deeper layers of the skin, thereby accelerating wound healing. This study evaluated the effectiveness of a 7% betel leaf extract nanospray on the healing of perineal wounds in postpartum care. The study employed a true experimental design with a pretest-posttest control group, involving 40 respondents selected through stratified random sampling. The variables examined were the use of 7% betel leaf extract nanospray and the healing of grade II perineal wounds. Data analysis was conducted using the Kruskal-Wallis test and the Mann Whitney, followed by the Wilcoxon test. The findings demonstrated that administration of Piper betle Linn 7% nanospray extract significantly accelerated perineal wound healing, as measured by the REEDA scale (p < 0.05), with the majority of the intervention group (65%) exhibiting good healing. However, there was no significant difference in IL-6 levels between the intervention and control groups (p > 0.05). Piper betle Linn 7% nanospray extract is effective in accelerating the healing of grade II perineal wounds in postpartum mothers, as indicated by a decrease in REEDA scores, but does not significantly affect the reduction of IL-6 levels.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Erna Indah Fitriyaningsih, Suryati Kumorowulan, Ari Suwondo, Sri Rahayu, Christin Hiyana TD

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International. that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.









